
|Articles|October 1, 2012
Nerve stimulation 'good option' in refractory voiding dysfunction
An implantable neurostimulator (InterStim, Medtronic, Minneapolis) improves voiding outcomes in patients with voiding dysfunction that is refractory to other therapies, a retrospective long-term follow-up of patients at a single center showed.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA removes warning labels on hormone replacement therapy
2
BioProtect Balloon Spacer shows sustained quality-of-life benefits in long-term study
3
Theranostic therapies expand frontline use in prostate cancer
4
Data support safe reinduction of nadofaragene firadenovec in NMIBC
5




















